FAS Wealth Partners Inc. Has $2.35 Million Stock Holdings in Lam Research Co. (NASDAQ:LRCX)

FAS Wealth Partners Inc. raised its stake in Lam Research Co. (NASDAQ:LRCXFree Report) by 0.7% in the 4th quarter, Holdings Channel.com reports. The fund owned 2,996 shares of the semiconductor company’s stock after buying an additional 22 shares during the quarter. FAS Wealth Partners Inc.’s holdings in Lam Research were worth $2,347,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Valued Wealth Advisors LLC acquired a new position in shares of Lam Research during the 4th quarter worth $30,000. Bollard Group LLC raised its holdings in shares of Lam Research by 60.0% during the 2nd quarter. Bollard Group LLC now owns 40 shares of the semiconductor company’s stock worth $26,000 after buying an additional 15 shares in the last quarter. Orion Capital Management LLC acquired a new position in shares of Lam Research during the 3rd quarter worth $25,000. BluePath Capital Management LLC acquired a new position in shares of Lam Research during the 3rd quarter worth $28,000. Finally, Resurgent Financial Advisors LLC acquired a new position in shares of Lam Research during the 2nd quarter worth $29,000. 84.61% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Lam Research

In related news, SVP Seshasayee Varadarajan sold 5,500 shares of the company’s stock in a transaction dated Monday, March 18th. The stock was sold at an average price of $922.41, for a total transaction of $5,073,255.00. Following the sale, the senior vice president now owns 22,095 shares in the company, valued at approximately $20,380,648.95. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In related news, Director Abhijit Y. Talwalkar sold 882 shares of the company’s stock in a transaction that occurred on Monday, April 1st. The stock was sold at an average price of $972.03, for a total transaction of $857,330.46. Following the transaction, the director now directly owns 10,541 shares of the company’s stock, valued at approximately $10,246,168.23. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, SVP Seshasayee Varadarajan sold 5,500 shares of the company’s stock in a transaction that occurred on Monday, March 18th. The stock was sold at an average price of $922.41, for a total value of $5,073,255.00. Following the transaction, the senior vice president now directly owns 22,095 shares in the company, valued at $20,380,648.95. The disclosure for this sale can be found here. Insiders have sold a total of 7,029 shares of company stock worth $6,559,489 in the last 90 days. Corporate insiders own 0.32% of the company’s stock.

Lam Research Trading Down 1.5 %

NASDAQ LRCX opened at $967.33 on Wednesday. The business’s 50-day moving average price is $917.08 and its two-hundred day moving average price is $770.03. Lam Research Co. has a 12 month low of $480.45 and a 12 month high of $1,007.39. The firm has a market capitalization of $126.82 billion, a PE ratio of 37.41, a price-to-earnings-growth ratio of 3.49 and a beta of 1.51. The company has a current ratio of 3.06, a quick ratio of 2.02 and a debt-to-equity ratio of 0.61.

Lam Research (NASDAQ:LRCXGet Free Report) last announced its earnings results on Wednesday, January 24th. The semiconductor company reported $7.52 EPS for the quarter, beating the consensus estimate of $7.06 by $0.46. Lam Research had a return on equity of 44.47% and a net margin of 24.15%. The company had revenue of $3.76 billion for the quarter, compared to analyst estimates of $3.71 billion. During the same quarter in the prior year, the company earned $10.71 EPS. The firm’s revenue for the quarter was down 28.8% compared to the same quarter last year. On average, analysts expect that Lam Research Co. will post 28.88 EPS for the current year.

Lam Research Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 3rd. Investors of record on Wednesday, March 13th will be given a dividend of $2.00 per share. The ex-dividend date is Tuesday, March 12th. This represents a $8.00 annualized dividend and a dividend yield of 0.83%. Lam Research’s payout ratio is 30.94%.

Wall Street Analyst Weigh In

A number of research firms have recently commented on LRCX. Raymond James boosted their price target on Lam Research from $850.00 to $950.00 and gave the stock an “outperform” rating in a report on Thursday, January 25th. Needham & Company LLC upped their target price on Lam Research from $800.00 to $900.00 and gave the stock a “buy” rating in a report on Thursday, January 25th. TD Cowen upped their target price on Lam Research from $710.00 to $975.00 and gave the stock an “outperform” rating in a report on Thursday, January 25th. Deutsche Bank Aktiengesellschaft cut Lam Research from a “buy” rating to a “hold” rating and upped their target price for the stock from $680.00 to $725.00 in a report on Tuesday, December 12th. Finally, Susquehanna upped their target price on Lam Research from $655.00 to $880.00 and gave the stock a “neutral” rating in a report on Monday, January 29th. Eight equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $826.68.

View Our Latest Stock Report on LRCX

Lam Research Company Profile

(Free Report)

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.

Featured Stories

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Co. (NASDAQ:LRCXFree Report).

Institutional Ownership by Quarter for Lam Research (NASDAQ:LRCX)

Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.